Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Completed 7Terminated 3Recruiting 3Active not recruiting 3Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1

Conditions

Tobacco Use 1Smoking Cessation 1Lung Neoplasms 1

Interventions

pembrolizumab 437Carboplatin 322Nivolumab 292Cyclophosphamide 281Specimen Handling 271Magnetic Resonance Spectroscopy 257Cisplatin 253Paclitaxel 248Radiotherapy 229Gemcitabine 183Biopsy 182Dexamethasone 181durvalumab 168atezolizumab 151Rituximab 138Doxorubicin 135Lenalidomide 134Bevacizumab 133Docetaxel 131Ipilimumab 129Capecitabine 120Radiation 118Oxaliplatin 114Radiosurgery 113Pemetrexed 112Etoposide 111Fluorouracil 110venetoclax 106fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Nicotine Replacement Therapy × Clear all
NCT05144542 2026-04-15

Risk and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer

M.D. Anderson Cancer Center

Phase NA Active not recruiting
140 enrolled
Thoracic

Lung Neoplasms

NCT03315910 2025-11-24

Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites

Memorial Sloan Kettering Cancer Center

Phase 4 Active not recruiting
807 enrolled

Smoking Cessation

NCT00575718 2025-10-10

Smoking Cessation Intervention for Cancer Patients

Memorial Sloan Kettering Cancer Center

Phase NA Active not recruiting
204 enrolled

Tobacco Use

Data powered by HemOnc (CC BY 4.0) Colophon âš¡